WO2009066181A3 - Pastilles de chlorhydrate de duloxétine pour administration orale à libération retardée - Google Patents
Pastilles de chlorhydrate de duloxétine pour administration orale à libération retardée Download PDFInfo
- Publication number
- WO2009066181A3 WO2009066181A3 PCT/IB2008/003741 IB2008003741W WO2009066181A3 WO 2009066181 A3 WO2009066181 A3 WO 2009066181A3 IB 2008003741 W IB2008003741 W IB 2008003741W WO 2009066181 A3 WO2009066181 A3 WO 2009066181A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- duloxentine
- release
- oral delayed
- hydrochloride pellets
- pellets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des pastilles de chlorhydrate de duloxétine pour administration orale à libération retardée. L'invention concerne en outre des procédés permettant leur préparation et leur utilisation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92969707P | 2007-07-09 | 2007-07-09 | |
US60/929,697 | 2007-07-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009066181A2 WO2009066181A2 (fr) | 2009-05-28 |
WO2009066181A3 true WO2009066181A3 (fr) | 2009-08-20 |
Family
ID=40667910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/003741 WO2009066181A2 (fr) | 2007-07-09 | 2008-07-09 | Pastilles de chlorhydrate de duloxétine pour administration orale à libération retardée |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR067502A1 (fr) |
WO (1) | WO2009066181A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2376095B1 (es) * | 2008-10-02 | 2013-01-24 | Laboratorios Del Dr. Esteve, S.A. | Pellets entéricos de duloxetina. |
US20120207825A1 (en) * | 2009-09-17 | 2012-08-16 | Sunilendu Bhushan Roy | Pharmaceutical compositions for reducing alcohol-induced dose dumping |
PL224543B1 (pl) | 2013-08-21 | 2017-01-31 | Pabianickie Zakłady Farm Polfa Spółka Akcyjna | Dojelitowa tabletka duloksetyny |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0693282A2 (fr) * | 1994-07-18 | 1996-01-24 | Eli Lilly And Company | Pilules entériques contenant de la duloxétine |
WO1997033880A1 (fr) * | 1996-03-11 | 1997-09-18 | Eli Lilly And Company | Methodes de traitement ou de prevention de la cystite interstitielle |
EP1640000A2 (fr) * | 2002-11-27 | 2006-03-29 | Boehringer Ingelheim International GmbH | Composition pharmaceutique comprenant un agoniste de l'adrénocepteur béta-3 et un inhibiteur de la recapture de la sérotonine et/ou de la norépinéphrine |
WO2007034503A2 (fr) * | 2005-06-20 | 2007-03-29 | Cadila Healthcare Limited | Formulation galenique a liberation commandee de duloxetine |
WO2007139886A2 (fr) * | 2006-05-22 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Formulations à libération retardée de chlorhydrate de duloxétine |
EP1938840A1 (fr) * | 2006-12-27 | 2008-07-02 | LEK Pharmaceuticals D.D. | Composition à base de Duletoxine |
WO2008129501A2 (fr) * | 2007-04-20 | 2008-10-30 | Wockhardt Research Centre | Compositions pharmaceutiques de duloxetine |
-
2008
- 2008-07-09 WO PCT/IB2008/003741 patent/WO2009066181A2/fr active Application Filing
- 2008-07-10 AR ARP080102970A patent/AR067502A1/es unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0693282A2 (fr) * | 1994-07-18 | 1996-01-24 | Eli Lilly And Company | Pilules entériques contenant de la duloxétine |
WO1997033880A1 (fr) * | 1996-03-11 | 1997-09-18 | Eli Lilly And Company | Methodes de traitement ou de prevention de la cystite interstitielle |
EP1640000A2 (fr) * | 2002-11-27 | 2006-03-29 | Boehringer Ingelheim International GmbH | Composition pharmaceutique comprenant un agoniste de l'adrénocepteur béta-3 et un inhibiteur de la recapture de la sérotonine et/ou de la norépinéphrine |
WO2007034503A2 (fr) * | 2005-06-20 | 2007-03-29 | Cadila Healthcare Limited | Formulation galenique a liberation commandee de duloxetine |
WO2007139886A2 (fr) * | 2006-05-22 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Formulations à libération retardée de chlorhydrate de duloxétine |
EP1938840A1 (fr) * | 2006-12-27 | 2008-07-02 | LEK Pharmaceuticals D.D. | Composition à base de Duletoxine |
WO2008129501A2 (fr) * | 2007-04-20 | 2008-10-30 | Wockhardt Research Centre | Compositions pharmaceutiques de duloxetine |
Non-Patent Citations (1)
Title |
---|
JANSEN P J ET AL: "CHARACTERIZATION OF IMPURITIES FORMED BY INTERACTION OF DULOXETINE HCI WITH ENTERIC POLYMERS HYDROXYPROPYL METHYLCELLULOSE ACETATE SUCCINATE AND HYDROXYPROPYL METHYLCELLULOSE PHTHALATE", JOURNAL OF PHARMACEUTICAL SCIENCE, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, vol. 87, no. 1, 1 January 1998 (1998-01-01), pages 81 - 85, XP000891949, ISSN: 0022-3549 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009066181A2 (fr) | 2009-05-28 |
AR067502A1 (es) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009066326A3 (fr) | Procédé amélioré pour la préparation de prasugrel et de ses sels pharmaceutiquement acceptables | |
IL194877A0 (en) | Duloxetine hydrochloride delayed release formulations | |
EP2043136A4 (fr) | Composition filmogene | |
IL210549A (en) | Pipedrine - Quinocosalin-Mediated Conjugated Drugs | |
EP2240173A4 (fr) | Composition pharmaceutique de duloxétine à libération retardée | |
WO2010056656A3 (fr) | Synthèse de chlorhydrate de palonosétron cristallin | |
WO2008129501A3 (fr) | Compositions pharmaceutiques de duloxetine | |
WO2010129636A3 (fr) | Lénalidomide polymorphe | |
WO2010065586A3 (fr) | Préparation de capécitabine | |
WO2012075015A3 (fr) | Compositions pharmaceutiques orales de métronidazole | |
PT2229062E (pt) | Processo de preparação de um hidrolisado | |
WO2010006904A3 (fr) | Nouvelles formes cristallines du rabéprazole sodique | |
WO2010015656A3 (fr) | Nouveaux alcoxypyrazoles | |
EP2051731A4 (fr) | Procédés pour réduire l'incidence d'une mastite | |
GB0910201D0 (en) | The preparation method of 2-deoxy-l-ribose | |
WO2011023954A3 (fr) | Formes polymorphes de manidipine | |
ZA200808011B (en) | Process for the isolation of calliterpenone (16alpha, 17-DiHyDroxy-S-Oxo-Phyllocladane) | |
ZA200901083B (en) | Modified release pharmaceutical composition of bupropion hydrochloride | |
SI2044099T1 (sl) | Postopek priprave S-fluorometil-6,9-difluoro-11-hidroksi-16-metil-17-propioniloksi-3-okso -androsta-1,4-dien-17-karbotioata in vmesnih spojin | |
HUP0700756A2 (en) | Process for the preparation of pharmaceutical intermediers | |
EP2083003A4 (fr) | Procédé de préparation de 1,1,1,3,3-pentachlorobutane | |
WO2009066181A3 (fr) | Pastilles de chlorhydrate de duloxétine pour administration orale à libération retardée | |
IL211062A0 (en) | Pharmaceutical uses of lanosta-8,24-dien-3-ols | |
EP2111285B8 (fr) | Procédé de préparation d'une composition d'agent réducteur | |
WO2008104957A3 (fr) | Nouvelles formes polymorphes d'hydrochlorure de milnacipran |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08851213 Country of ref document: EP Kind code of ref document: A2 |